145 related articles for article (PubMed ID: 37728367)
1. Neurotropism of SARS-CoV-2: A Pathological Examination of Neurosurgical Specimens.
Fujii T; Rennert RC; Hurth KM; Ward PM; Campan M; Mathew AJ; Dubeau L; Wallace WD; Liu CY; Russin JJ
Neurosurgery; 2024 Feb; 94(2):379-388. PubMed ID: 37728367
[TBL] [Abstract][Full Text] [Related]
2. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
3. Brainstem arteriovenous malformations: anatomical subtypes, assessment of "occlusion in situ" technique, and microsurgical results.
Han SJ; Englot DJ; Kim H; Lawton MT
J Neurosurg; 2015 Jan; 122(1):107-17. PubMed ID: 25343188
[TBL] [Abstract][Full Text] [Related]
4. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
Pouga L
J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
[TBL] [Abstract][Full Text] [Related]
5. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
Li YC; Zhang Y; Tan BH
J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
9. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.
Khan M; Clijsters M; Choi S; Backaert W; Claerhout M; Couvreur F; Van Breda L; Bourgeois F; Speleman K; Klein S; Van Laethem J; Verstappen G; Dereli AS; Yoo SJ; Zhou H; Dan Do TN; Jochmans D; Laenen L; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Meersseman P; Neyts J; Thal DR; Topsakal V; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
Neuron; 2022 Dec; 110(23):3919-3935.e6. PubMed ID: 36446381
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.
Matschke J; Lütgehetmann M; Hagel C; Sperhake JP; Schröder AS; Edler C; Mushumba H; Fitzek A; Allweiss L; Dandri M; Dottermusch M; Heinemann A; Pfefferle S; Schwabenland M; Sumner Magruder D; Bonn S; Prinz M; Gerloff C; Püschel K; Krasemann S; Aepfelbacher M; Glatzel M
Lancet Neurol; 2020 Nov; 19(11):919-929. PubMed ID: 33031735
[TBL] [Abstract][Full Text] [Related]
11. Urgent Neurosurgical Interventions in the COVID-19-Positive Pediatric Population.
Lang SS; Gajjar AA; Tucker AM; Storm PB; Rahman RK; Madsen PJ; O'Brien A; Chiotos K; Kilbaugh TJ; Huh JW
World Neurosurg; 2022 Feb; 158():e196-e205. PubMed ID: 34718196
[TBL] [Abstract][Full Text] [Related]
12. Comparison of In Situ Hybridization, Immunohistochemistry, and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Tissue.
Roden AC; Vrana JA; Koepplin JW; Hudson AE; Norgan AP; Jenkinson G; Yamaoka S; Ebihara H; Monroe R; Szabolcs MJ; Majumdar R; Moyer AM; García JJ; Kipp BR
Arch Pathol Lab Med; 2021 Jul; 145(7):785-796. PubMed ID: 33720333
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
14. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
15. Brain stem encephalitis is a rare complication of COVID-19.
Shamier MC; Crijnen YS; Bogers S; IJpelaar JW; de Vries JM; van der Jagt M; Spoor JKH; von der Thüsen JH; Schreurs MWJ; GeurtsvanKessel CH; Titulaer MJ
J Neuroimmunol; 2023 Jan; 374():578007. PubMed ID: 36481703
[TBL] [Abstract][Full Text] [Related]
16. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
17. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
[TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.
Pennisi M; Lanza G; Falzone L; Fisicaro F; Ferri R; Bella R
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751841
[TBL] [Abstract][Full Text] [Related]
20. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
